Elevation Oncology, Inc. Quarterly Marketable Securities, Current in USD from Q4 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Elevation Oncology, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2021 to Q2 2024.
  • Elevation Oncology, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $51.4M, a 3117% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $51.4M +$49.8M +3117% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $13.4M -$4.61M -25.6% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $33.9M -$10.5M -23.7% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $39.9M -$15.4M -27.8% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $1.6M -$67.1M -97.7% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $18M -$61M -77.2% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $44.4M +$44.4M Dec 31, 2022 10-K 2024-03-06
Q3 2022 $55.3M Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $68.7M Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $79.1M Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.